Skip to content
1887

Journal of Medical Microbiology logo Journal of Medical Microbiology

Volume 74, Issue 7

Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of infection in patients with lung cancer Open Access

Abstract

pneumonia (PJP, formerly known as pneumonia), an opportunistic fungal infection caused by the fungus , is a severe pulmonary infection that primarily affects immunocompromised patients, including those with lung cancer. Traditional diagnostic methods for PJP, such as Grocott–Gomori’s methenamine silver staining and real-time PCR, have limitations, including low positivity and high missed diagnosis rates.

Despite the critical need for accurate and sensitive diagnostic tools for PJP, especially in immunocompromised populations, existing methods fall short in providing the necessary reliability and efficiency.

This study aims to evaluate the efficacy of nanopore-based metagenomic third-generation sequencing in diagnosing infection in lung cancer patients, hypothesizing that this approach may offer superior sensitivity and specificity.

A prospective observational study was conducted on 118 lung cancer patients with suspected pulmonary infection at the Sixth Hospital of Nantong City, China, from January 2021 to December 2023. The identification of pathogens in bronchoalveolar lavage fluid samples was performed using both metagenomics and traditional tests.

Metagenomics showed a significantly higher detection rate of (33.0%) compared to methenamine silver staining (4.2%) and real-time PCR (30.5%). The sensitivity, specificity and accuracy of metagenomics detection were all 100%, which is markedly superior to traditional methods. Furthermore, metagenomics also identified mixed infections with other pathogens, such as and Epstein–Barr virus.

Metagenomics technology demonstrates high sensitivity and specificity in diagnosing infection, including mixed infections with other pathogens, in lung cancer patients. It provides a clear direction for clinical treatment and is a powerful tool for diagnosing PJP, contributing to improved diagnostic efficiency and accuracy, reducing misdiagnosis and missed diagnosis rates and improving clinical outcomes in these patients.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): diagnosis , lung cancer , metagenomics , nanopore-based third-generation sequencing and Pneumocystis jirovecii
© 2025 The Authors
  • This is an open-access article distributed under the terms of the Creative Commons Attribution License.
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.002031
2025-07-03
2025-07-10
Loading full text...

Full text loading...

/deliver/fulltext/jmm/74/7/jmm002031.html?itemId=/content/journal/jmm/10.1099/jmm.0.002031&mimeType=html&fmt=ahah

References

  1. Catherinot E, Lanternier F, Bougnoux M-E, Lecuit M, Couderc L-J et al. Pneumocystis jirovecii pneumonia. Infect Dis Clin North Am 2010; 24:107–138 [View Article] [PubMed]
     [Google Scholar]
  2. Fishman JA, Gans H. Pneumocystis jiroveci in solid organ transplantation: guidelines from the american society of transplantation infectious diseases community of practice. Clin Transplant 2019; 33:e13587 [View Article] [PubMed]
     [Google Scholar]
  3. Kim T, Moon SM, Sung H, Kim M-N, Kim S-H et al. Outcomes of non-HIV-infected patients with Pneumocystis pneumonia and concomitant pulmonary cytomegalovirus infection. Scand J Infect Dis 2012; 44:670–677 [View Article] [PubMed]
     [Google Scholar]
  4. Özkoç S, Ergüden Gürbüz C, Sayıner AA, Bayram Delibaş S. Evaluation of real-time polymerase chain reaction in Pneumocystis jirovecii laboratory diagnosis. Mikrobiyol Bul 2020; 54:418–428 [View Article] [PubMed]
     [Google Scholar]
  5. Ettinger DS, Wood DE, Aisner DL, Akerley W, Bauman J et al. Non-small cell lung cancer, version 5.2017, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 2017; 15:504–535 [View Article] [PubMed]
     [Google Scholar]
  6. Zhong Y, Ji T, Qin D, Cheng D. Clinical characteristics and risk factors of in-hospital mortality in patients coinfected with Pneumocystis jirovecii and Aspergillus. J Mycol Med 2023; 33:101330 [View Article] [PubMed]
     [Google Scholar]
  7. Takeda K, Harada S, Hayama B, Hoashi K, Enokida T et al. Clinical characteristics and risk factors associated with Pneumocystis jirovecii infection in patients with solid tumors: study of thirteen-year medical records of a large cancer center. BMC Cancer 2021; 21:987 [View Article] [PubMed]
     [Google Scholar]
  8. Lee EH, Kim EY, Lee SH, Roh YH, Leem AY et al. Risk factors and clinical characteristics of Pneumocystis jirovecii pneumonia in lung cancer. Sci Rep 2019; 9:2094 [View Article] [PubMed]
     [Google Scholar]
  9. Teh BW, Azzato FA, Lingaratnam SM, Thursky KA, Slavin MA et al. Molecular diagnosis of Pneumocystis jirovecii in patients with malignancy: clinical significance of quantitative polymerase chain reaction. Med Mycol 2014; 52:427–432 [View Article] [PubMed]
     [Google Scholar]
  10. Gülbudak H, Öztürk C, Kuyugöz S, Tezcan Ülger S. Investigation of Pneumocystis jirovecii infection and colonization in immunocompromised patients with pneumonia. Mikrobiyol Bul 2020; 54:583–595 [View Article] [PubMed]
     [Google Scholar]
  11. Sun H, Wang F, Zhang M, Xu X, Li M et al. Diagnostic value of bronchoalveolar lavage fluid metagenomic next-generation sequencing in Pneumocystis jirovecii pneumonia in Non-HIV immunosuppressed patients. Front Cell Infect Microbiol 2022; 12:872813 [View Article] [PubMed]
     [Google Scholar]
  12. Cooley L, Dendle C, Wolf J, Teh BW, Chen SC et al. Consensus guidelines for diagnosis, prophylaxis and management of Pneumocystis jirovecii pneumonia in patients with haematological and solid malignancies, 2014. Intern Med J 2014; 44:1350–1363 [View Article] [PubMed]
     [Google Scholar]
  13. Schildgen V, Mai S, Khalfaoui S, Lüsebrink J, Pieper M et al. Pneumocystis jirovecii can be productively cultured in differentiated CuFi-8 airway cells. mBio 2014; 5:e01186-14 [View Article] [PubMed]
     [Google Scholar]
  14. Wang D, Fang S, Hu X, Xu Q, Chu X et al. Metagenomic next-generation sequencing is highly efficient in diagnosing Pneumocystis Jirovecii pneumonia in the immunocompromised patients. Front Microbiol 2022; 13:913405 [View Article]
     [Google Scholar]
  15. Tekin A, Truong HH, Rovati L, Lal A, Gerberi DJ et al. The diagnostic accuracy of metagenomic next-generation sequencing in diagnosing Pneumocystis pneumonia: a systemic review and meta-analysis. Open Forum Infect Dis 2023; 10:ofad442 [View Article] [PubMed]
     [Google Scholar]
  16. Adler A, Poirier S, Pagni M, Maillard J, Holliger C. Disentangle genus microdiversity within a complex microbial community by using a multi-distance long-read binning method: example of Candidatus Accumulibacter. Environ Microbiol 2022; 24:2136–2156 [View Article] [PubMed]
     [Google Scholar]
  17. Bassi C, Guerriero P, Pierantoni M, Callegari E, Sabbioni S. Novel virus identification through metagenomics: a systematic review. Life 2022; 12:2048 [View Article] [PubMed]
     [Google Scholar]
  18. Ip HS, Uhm S, Killian ML, Torchetti MK. An evaluation of avian influenza virus whole-genome sequencing approaches using nanopore technology. Microorganisms 2023; 11:529 [View Article] [PubMed]
     [Google Scholar]
  19. Arcenas RC, Uhl JR, Buckwalter SP, Limper AH, Crino D et al. A real-time polymerase chain reaction assay for detection of Pneumocystis from bronchoalveolar lavage fluid. Diagn Microbiol Infect Dis 2006; 54:169–175 [View Article] [PubMed]
     [Google Scholar]
  20. Lai G, Zeng C, Mo J, Song W-D, Xu P. Diagnostic value of galactomannan in bronchoalveolar lavage fluid for chronic respiratory disease with pulmonary aspergillosis. J Clin Microbiol 2020; 58:e01308-19 [View Article] [PubMed]
     [Google Scholar]
  21. Nassar A, Zapata M, Little JV, Siddiqui MT. Utility of reflex gomori methenamine silver staining for Pneumocystis jirovecii on bronchoalveolar lavage cytologic specimens: a review. Diagn Cytopathol 2006; 34:719–723 [View Article] [PubMed]
     [Google Scholar]
  22. Hall MB, Rabodoarivelo MS, Koch A, Dippenaar A, George S et al. Evaluation of nanopore sequencing for Mycobacterium tuberculosis drug susceptibility testing and outbreak investigation: a genomic analysis. Lancet Microbe 2023; 4:e84–e92 [View Article] [PubMed]
     [Google Scholar]
  23. Wilson JW, Limper AH, Grys TE, Karre T, Wengenack NL et al. Pneumocystis jirovecii testing by real-time polymerase chain reaction and direct examination among immunocompetent and immunosuppressed patient groups and correlation to disease specificity. Diagn Microbiol Infect Dis 2011; 69:145–152 [View Article] [PubMed]
     [Google Scholar]
  24. Lee JH, Jang JH, Park JH, Lee S, Kim JY et al. Prevalence and clinical impacts of obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: a single-center, retrospective study. PLoS One 2023; 18:e0291195 [View Article] [PubMed]
     [Google Scholar]
  25. Truong J, Ashurst JV. Pneumocystis jirovecii pneumonia. statpearls. Treasure Island 2021
     [Google Scholar]
  26. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa J-M et al. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol 2012; 50:227–231 [View Article] [PubMed]
     [Google Scholar]
  27. Miao Q, Ma Y, Wang Q, Pan J, Zhang Y et al. Microbiological diagnostic performance of metagenomic next-generation sequencing when applied to clinical practice. Clin Infect Dis 2018; 67:S231–S240 [View Article] [PubMed]
     [Google Scholar]
  28. Del Corpo O, Butler-Laporte G, Sheppard DC, Cheng MP, McDonald EG et al. Diagnostic accuracy of serum (1-3)-β-D-glucan for Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis. Clin Microbiol Infect 2020; 26:1137–1143 [View Article] [PubMed]
     [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.002031
Loading
Diagnostic value of nanopore-based metagenomic third-generation sequencing in the diagnosis of Pneumocystis jirovecii infection in patients with lung cancer
J. Med. Microbiol. 74, 002031 (2025); https://doi.org/10.1099/jmm.0.002031
/content/journal/jmm/10.1099/jmm.0.002031
/content/journal/jmm/10.1099/jmm.0.002031
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error